|
1 Dong YS. Keep further research of cytomegalovirus infection[J]. Chin J Pediatr, 1995, 33(1): 3-4. [董永绥.继续深入进行巨细胞病毒感染的研究[J].中华儿科杂志，1995, 33(1): 3-4.]
|
|
2 Chen PY, Xie ZD, Wang T. Clinical investigation on Ganciclovir applied to treat neonatal congenital CMV infection[J]. J Chin Physician, 2003, 5(4)：502-504. [陈平洋，谢宗德，王涛．更昔洛韦治疗新生儿先天性巨细胞病毒感染的临床研究[J]．中国医师杂志，2003，5(4)：502-504.]
|
|
3 Azam A, Vial Y, Fawer C, et al. Prenatal diagnosis of congenital cytomegalovirus infection[J]. Obstet Gynaecol, 2001, 97(3): 443-448.
|
|
4 Wu PQ. 186 CMV infected pediatric patients[J]. J Pract Med, 2008, 24(3): 2189.[吴佩琼．小儿巨细胞病毒感染186例[J].实用医学杂志，2008, 24(3): 2189.]
|
|
5 Leung AK, Sauve RS, Davies HD. Congenital cytomegalovirus infection[J]. J Natl Med Assoc, 2003, 95(3): 213-218.
|
|
6 Wang B, Sun M. The effect on hearing in children with symptomatic cytomegalovirus infection[J]. Chin J Birth Health Hered, 2005, 13(4): 108-111. [王冰，孙梅.有症状的婴儿巨细胞病毒感染对听力的影响[J].中国优生与遗传杂志，2005, 13(4): 108-111.]
|
|
7 Zhou L, Fang F. Diagnostic and therapeutic advances on congenital cytomegalovirus infection[J]. Med Recapitulate, 2005, 11(7): 626-628. [周霖，方风.先天性巨细胞病毒感染的诊疗进展[J].医学综述，2005, 11(7): 626-628.]
|
|
8 Yan SY, Chen PY. The development of laboratory diagnosis of human cytomegalovirus infection[J]. Foreign Med Sci Sec Pediatr, 2005, 32(5): 284-287. [闫淑媛，陈平洋.人巨细胞病毒感染的实验室诊断研究进展[J].国外医学·儿科学分册，2005, 32(5): 284-287.]
|
|
9 Bhatia J, Shan BV, Mehta AP, et al. Comparing serology，antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients[J]. J Assoc Physicians India, 2004, 4(5): 297-300.
|
|
10 Sun Z, Ceng X, Mao Z, et al. Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants[J]. Med Microbiol Immunol, 2009, 198(2): 107-112.
|
|
11 Wang LX. Clinical detection of CMV in allogeneic bone marrow transplantation[J]. J Exp Hematol, 2004, 12(6): 880-884. [王列样．异基因骨髓移植中巨细胞病毒的临床检测[J]．中国实验血液学杂志，2004, 12(6): 880-884.]
|
|
12 Revello MG, Lilleri D, Zavattoni M, et al. Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic by nucleic acid sequence-based amplification assay[J]. J Clin Microbiol, 2003, 41(4): 1772 -1774.
|
|
13 Gandhoke I, Aggarwal R, Hussain SA, et al. Congenital CMV infection: Diagnosis in symptomatic infants[J]. Indian J Med Micro, 2009, 27(3)：222-225.
|
|
14 Dong HF, Pan JH, Li L, et al. Clinical therapeutic effect of ganciclovir on neonatal congenital cytomegalovirus infection[J]. Appl J Gen Pract, 2007, 5(5): 396-397. [董淮富，潘家华，李莉，等．更昔洛韦治疗先天性巨细胞病毒感染疗效观察[J]．实用全科医学，2007, 5(5): 396-397.]
|
|
15 Xu YP, Wu T, Zheng JY. Long-term effect of ganciclovir against congenital and perinatal CMV infection[J]. Matern Child Health Care China, 2006, 21(21): 2970-2972. [徐亚萍，吴苔，郑季彦.更昔洛韦对先天性与围产期巨细胞病毒感染远期疗效[J].中国妇幼保健，2006, 21(21): 2970-2972.]
|
|
16 Marshall, Beth C, Koch, et al. Antiviral for cytomegalovirus infection in neonates and infants[J]. Pediatr Drugs, 2009, 11(5): 309-321.
|
|
17 Yu ZL. Effect of treating infant cytomegalovirus hepatitis with ganciclovir[J]. J Appl Clin Pediatr, 2004, 19(5): 424-425. [于兆莉.更昔洛韦治疗婴儿巨细胞病毒肝炎疗效观察[J]．实用儿科临床杂志，2004, 19(5): 424-425.]
|
|
18 Zhao QW, Li XJ, Huan YF. Evaluating the effect of ganciclovir on infant cytomegalovirus hepatitis[J]. J Pediatr Pharm, 2003, 9(5): 27-28. [赵庆卫，李学娟，黄延风.更昔洛韦治疗婴儿巨细胞病毒性肝炎的疗效评价[J]．儿科药学杂志，2003, 9(5): 27-28.]
|
|
19 Ohta H, Matsuda Y, Tokimasa, et al. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: Effective monitoring of CMV infection by quantitative analysis of CMV mRNA[J]. Bone Marrow Transplant, 2001, 27(11): 1141-1145.
|
|
20 Liang SM, Gou X, Wu XH, et al. Forscarnet sodium in treatment of 25 patients with cytomegalovirus antigenemia after renal transplantation[J]. Chin J New Drugs Clin Rem, 2007, 26(1): 55-58. [梁思敏，苟欣，吴小候，等.膦甲酸钠治疗肾移植后巨细胞病毒抗原血症25例[J].中国新药与临床杂志，2007, 26(1): 55-58.]
|
|
21 Mehrdad M, Lottie S, Britta W, et al. Point mutations induced by foscarnet(PFA) in the human cytomegalovirus DNA polymerase[J]. J Clin Virol, 2003, 26(2): 301-306.
|
|
22 Ljungman P, Deliliers GL, Platzbecker U, et al. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients[J]. Blood, 2001, 97(2): 388-392.
|
|
23 Du YH, Kou XH, Zhang LH, et al. The clinical research of infection and specific therapy of cytomegalovirus in pregnant women and neonates[J]. Chin J Fam Plann, 1998, 11: 502-503. [杜玉华，寇秀花，张立华，等.孕妇和新生儿CMV感染及其特异性治疗的临床研究[J].中国计划生育学杂志，1998, 11: 502-503.]
|
|
24 Han DM, Yin W, Chen XQ. Study advances on prevention and treatment of HCMV with monoclonal antibody[J]. Int J Epidemiol Infect Dis, 2004, 31(3): 158-160. [韩冬梅，尹文，陈协群.单克隆抗体防治HCMV感染的研究进展[J].国外医学．流行病学传染病学分册，2004, 31(3): 158-160.]
|
|
25 Hanley PJ, Cruz CR, Savoldo B, et al. Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes[J]. Blood, 2009, 114(9)：1958-1967.
|
|
26 Wang H, Li T, Lin XZ, et al. The role of NF-κB in the inhibitory effects of Chinese medicine JinyeBaidu(JYBD) on human cytomegalovirus infection[J]. Chin J Birth Herd, 2008, 16(5)：18-19. [汪辉，李天，凌霞珍等．核转录因子-κB在中药金叶败毒制剂抗人巨细胞病毒感染中的作用[J].中国优生与遗传杂志，2008, 16(5): 18-19.]
|
|
27 Zhen H, Fang F, Shu SN, et al. Inhibition on immediate early gene expression, an important mechanism of allitridin anti-HCMV effects[J]. Chin J Evid Based Pediatr, 2006, 1(1): 26-32. [甄宏，方峰，舒赛男，等.大蒜新素抑制人巨细胞病毒即刻早期基因表达在抗人巨细胞病毒机制中的作用[J].中国循证儿科杂志，2006, 1(1): 26-32.]
|